rise beyond e r n r e v e w table contents creating better healthier world building sustainability resilience report responsible growth strategy letter chairman chief executive officer daniel oday environmental impact reduction financial highlights business resiliency behind work safety ethics transparency innovation future elevating impact society rising beyond giving back communities covid response covid support helps fill unmet needs innovation hiv antivirals support racial justice growth oncology programs ongoing lgbtq support addressing hiv communities going workforce appendix life gilead supporting people gilead commitment racial equity governing principles driving change opportunity code stand cultural evolution approach csr growing global workforce materiality workplace safety approach tax global reporting initiative gri index sustainability accounting standards board sasb index section creating report year review annual report highlighting better gileads business performance corporate activities environmental social governance esg data align data collection measurement reporting activities industryleading frameworks including united healthier nations global compact ungc united nations sustainable development goals un sdgs global reporting initiative gri carbon disclosure project cdp frameworks report prepared accordance world gri standards core option reports scope includes entities listed gileads annual report focuses esg topics material gileads business operations phrase materiality used context report materiality review process different definition used context filings us securities exchange commission sec issues deemed material purposes report purposes determining esg strategies may considered material sec reporting purposes dara burdette discovery virology forwardlooking report content statements period boundary report includes forwardlooking statements within line gris principles defining report content meaning private securities litigation reform act gilead considered stakeholder inclusiveness sustainability subject risks uncertainties context materiality completeness reporting factors risks uncertainties factors principles developing year review described detail gileads periodic reports filed activities data contained report cover sec including current reports form k quarterly period january december reports form q annual reports environmental data reporting periods risks uncertainties factors could cause indicated provide updated figures actual results differ materially referred website data validation verification complete forwardlooking statements statements see environmental data content period boundary statements historical fact statements could information regularly reevaluate reporting deemed forwardlooking statements reader boundaries material topics ensure current cautioned rely forwardlooking statements complete see materiality information forwardlooking statements based information material topic boundaries currently available gilead gilead assumes obligation update forwardlooking statements world tested scale pandemic became known gilead set addressing significant responsibilities ways could never imagined several fronts protect safety letter covid pandemic employees contribute longstanding expertise antiviral therapies fight covid devastating impact across globe time important maintain commitments chairman yet also demonstrated patients stay track existing plans objectives end able look strength resilience chief executive back knowing carried responsibilities ability overcome great challenges reinforced gileads path strong future officer reminded gileads longterm research emerging viruses important much decades investment antiviral therapies allowed us capable achieving move quickly start pandemic work previously done veklury daniel oday pull together seen potential treatment covid entire company rallied contribute work veklury expanded manufacturing capability ran multiple clinical studies collaborated many partners bring therapy patients veklury became first fdaapproved therapy covid end used treat one two patients hospitalized covid united states used treat millions patients worldwide made available lowerincome countries voluntary licenses reminded us much world depends responding urgent global needs responsibility planet also front center scientific innovation important role pandemic placed strong emphasis safety gilead corporate social responsibility committee biopharmaceutical industry companies rallied come employees particularly paramount responsible integrating climate change energy ways help address covid pandemic teams continued work gileads manufacturing material esg issues overall business employing best scientific expertise collaborating facilities labs pandemic took careful strategy operations committed multiple ways less emphasis many steps support employees safeguarding setting ambitious new goals around climate energy diseases conditions exist throughout world wellbeing families gilead increased throughout report learn gilead companies continued bring forward new employee base particular focus many ways gilead working ensure healthier safer medicines maintained ongoing supply existing expanding expertise oncology hired many equitable world operating therapies even delivering veklury managing talented leaders welcomed new members environmentally responsible manner uncertainties created pandemic gilead board directors ensured ongoing supply medicines patients many lessons delivered perhaps memoriam depend hiv treatment prevention cell role companies like driving positive important reminder nothing john c martin phd therapy cancer ability rise challenges societal change took additional significance precious health goal improving global pandemic demonstrates extent resilience disproportionate impact pandemic public health inspires drives us report completed learned great communities highlighted need drive health work gilead look forward delivering sadness passing john c martin phd former significantly strengthened diversified portfolio equity year also provided us stark reminders many opportunities chairman chief executive officer scientific vision new medicines recent additions include several work eliminate racial injustice leadership helped transform lives millions patients new marketed therapies trodelvy firstinclass major employer see responsibility take shape gilead company today joined gilead therapy could transform treatment certain type action help address issues behalf sincerely six years later became chief executive officer role breast cancer potential treating multiple employees communities serve daniel oday held years steered company tumor types also continued advance pipeline societies operate gilead always seen period remarkable growth introducing series new new medicines development including important progress role going beyond medicine innovative medicines helped fundamentally change investigational longacting therapy hiv lenacapavir increased efforts increase equity kinds improve treatment people living hiv viral hepatitis gileads portfolio targets even broader set unmet internal programs external partnerships funding johns legacy felt generations come living medical needs setting us clear path growth communitybased organizations scientific progress made leadership driving benefits patients shareholders programs pioneered expanded access medicines people around world financial highlights research cash used acquisitions total revenues development expenses b b b excludes acquired inprocess research development expenses billion cash flows cash cash equivalents operating activities debt repayments marketable securities b b b represents balance december share repurchases cash dividend payments b b b product sales strategic partnerships acquisitions gilead delivered strong financial performance despite total global product sales announced strategic partnerships acquisitions goal global impact covid pandemic reflection solid expanding commercial portfolio clinical pipeline across therapeutic areas underlying fundamentals business driven robust hiv b notably oncology drive future growth continued use strong balance business ability execute development veklury remdesivir also experienced growth sales cell therapy geographies sheet pursue tailored transactions drive strategic value treatments kite gilead company kite patients b received yescarta axicabtagene ciloleucel launched tecartus brexucabtagene autoleucel united states europe treatment mantle cell lymphoma global product sales totaled billion representing growth b product sales billion united states billion united states europe billion geographies license research license research research staged license acquisition acquisition agreement collaboration agreement collaboration collaboration acquisition agreement hiv celltherapy celltherapy celltherapy immunooncology immunooncology immunooncology immunooncology hepatitisdeltavirus undisclosed partner technology acquisition research asset staged research discovery collaboration research license collaboration purchase acquisition collaboration collaboration collaboration hiv immunooncology inflammation hiv immunooncology immunooncology celltherapy celltherapy immunooncology h h acquisition closed pioneered products gilead also focused expanding expertise foundation oncology past year significantly since founding including first added portfolio complement existing strengths single tablet regimen treat hiv first behind work help people cancer medicine prevent hiv put drive determination work respect people core progress highly hepatitis c virus hcv enabled us committed creating inclusive culture one enables deliver four curative hcv therapies less people best work reflects diversity gilead work create healthier people patients communities serve four years leader cell therapy evolving workplace onsite virtual achieve world people delivering committed changing way cancer ambition biotech employer choice innovative medicines aim prevent treated developing onetime treatments employees well hope treat cure lifethreatening diseases curative intent deep antiviral knowledge attract gilead future paired commitment treating global pursue advancements science health crises also helped us rapidly advance recognize takes medicines goal improving care areas meaningfully improve care people lifethreatening deliver veklury first treatment unmet medical need setting diseases strive go beyond science address covid approved us food drug social structural challenges global programs seek make impossible possible administration fda reduce healthcare disparities reducing barriers care include stigma discrimination access healthcare services addition efforts advance healthcare equity communities continue focus reducing environmental footprint global sammy metobo sustainability strategy medicinal chemistry innovation future also strengthened portfolio adding four marketed products clinical stage clinicalstage nmes via programs inlicensing acquisitions trodelvy fda accounting programs sacituzumab govitecanhziy tecartus fda jyseleca european commission filgotinib ndablamaa breakthrough therapy filings phase designations veklury fda registrational phase trials also announced plans acquire fifth including inlicensed acquired programs currently phase ndablamaa approval medicine hepcludex bulevirtide pursuant acquisition myr gmbh myr completed march sesaesid lariv yrotammaflni ygolocno sesaesid clinical pipeline end phase phase phase filed phase maa filed maa bla approved sbla filed sbla sbla aa pivotal pivotal phase b phase b phase b phase b phase phase addressing global challenges gilead demonstrates commitment principles outlined ungc un sdgs ungc calls companies align operations universally accepted principles human rights labor environment anticorruption stemming ungc un sdgs identify impact areas help society achieve better sustainable future aligning gileads existing sustainability social practices within ungc un sdg frameworks allows us better convey commitments patients local communities society planet although gilead supports un sdgs identified specific goals deliver greatest influence positive impact particular work provide lifesaving medicines underserved communities aligns strongly un sdg good health wellbeing committed supporting global health sustainable development business operations additional information alignment work un sdgs found appendix gri content index report section rising beyond gilead dedicated looking beyond obvious solve complex problems read efforts rise beyond worked amid pandemic deliver patients nathan wright medicinal chemistry covid response covid outbreak began emerge well even clinical trials demonstrated veklurys efficacy declared pandemic world health organization patients covid accelerated production capacity gileads scientists took note asked given assembled international group pharmaceutical decades antiviral expertise could help began chemical manufacturers help global supply needs examine potential theninvestigational antiviral expand supply veklury gilead also signed veklury shown potential utility nonexclusive voluntary licensing agreements generic coronaviruses laboratory preclinical experiments drugmakers india egypt pakistan early first patient received veklury treatment covid special regulatory emergency use fda granted emergency use authorization veklury process prepared possibility rapidly may late october less year initiating clinical trials evaluate veklury investigational first case report disease veklury received fda treatment covid approval treatment covid patients requiring hospitalization lorena catano packaging operations impact innovating treat covid gilead responded quickly advance veklury deploying decades antiviral expertise significant internal resources help patients communities working ease burden pandemic end year approximately million people united states received veklury anu osinusi virology hepatitis respiratory emerging viruses increasing veklury supply partners new longstanding instrumental providing adequate supply gilead invested ramping manufacturing seeing clinical data demonstrated clinical trials medicines efficacy without compromising safety rigor gilead teams worked collaboratively find expedited ways shorten manufacturing process bring additional manufacturing completed clinical trials rapidly partners maintaining highest bar safety collaboration patients healthcare providers regulatory authorities clinical trial investigators donation end june gilead provided entire existing supply veklury cost clinical trials emergency access programs countries medicine received regulatory authorization help veklury reach patients quickly possible light public emergency posed pandemic gilead ramps prompted gilead proactively ramp manufacturing capabilities qa early company veklury began quick cascade events starting late gilead colleagues received information regarding emerging cases pneumonia could signs new coronavirus since gilead recently studying theninvestigational manufacturing veklury treatment middle east respiratory syndrome mers deadly disease caused coronavirus considered possible connection companys leadership team convened task force determine best evaluate veklury treatment covid outcomes promising produce large quantities would needed potential pandemic setting midjanuary got news prepare make veklury scale early data promising qa ken kent senior vice president chemical development first manufacturing operations steps team took ramp production covid outbreak became making veklury requires long chemical synthesis must done sequentially step one two three global pandemic gileads deep history cant simply assemble needed ingredients antiviral drug development suggested meant needed quickly work global one companys medicines could suppliers existing partners additional manufacturing partners secure raw materials even knew potentially used treat virus veklury would work new coronavirus within short months materials began arriving around ken kent takes us behind scenes globe large quantities components readily share gilead took bold action available would also help eliminate bottlenecks caused one material running low meet unmet global need also made changes reduce proud journey initially month manufacturing process six eight going modest stockpile medicine start year enough months hand october meet global needs truly took village wouldnt happened without hard work long hours enthusiastic collaboration manufacturing partners regulatory counterparts global team employees rose beyond tasked team chemists finding ways speed limitations fight one defining challenges time production veklury efficiencies found largely due process improvements changes added enabled us reduce manufacturing time six eight months without compromising quality safety important small stockpile product hand potential needing much soon real possibility able increase supply enough treat patients january million treatment courses end year production capacity began accelerate started receiving raw materials ordered january continued make improvements throughout year allowing manufacturing teams produce larger batches medicine gilead employees la verne california expanding voluntary licensing green chemistry reduces production agreements remdesivir environmental impact covid pandemic brought world halt gilead signed nonexclusive voluntary licensing even worked advance veklury rapidly gilead employees worked diligently advance agreements generic pharmaceutical manufacturers remained focused decreasing environmental companys theninvestigational antiviral laura bauer expand supply remdesivir agreements footprint principles green chemistry designing scientist formulation process development allow companies manufacture remdesivir chemical products processes reduce eliminate group collaborated team colleagues partners distribution countries nearly generation hazardous substances day across wide manufacturing supply chain network resource limited licenses currently remain today discipline improved total process mass increase production learn watch realizing royaltyfree reflecting gileads existing commitment intensity pmi score veklury reduction possible video enabling broad patient access remdesivir solvents reagents reactants consumables innovation led us use fewer resources enabling us produce faster see advancing green chemistry section report laura bauer formulation process development strengthening ensuring continuity cell global supply chain delivery patients covid pandemic caused commercial flights top priority safeguard minimize potential reduced flights transport many impact pandemic access kites cancertreating medicines gileads global supply chain team found cell therapies cell therapies represent truly opportunities overcome delivery barriers employees personalized medicine made using patients made immediate logistical changes established cells transportation plays integral role getting longerterm systems automation improvements therapy patients patients receive cell therapy employees went beyond daytoday roles showing often sick dont time wait treatment dedication ensure medicines reached patients potential delays serious consequences amid global around world travel restrictions threat supply chain disruptions employees worked tirelessly ensure timely leaned urgency pandemic accelerate manufacture supply delivery lifesaving therapies ongoing enhancements supply planning logistics eligible patients around world systems helped speed medicines patients also built stronger foundation future ensure continuity treatment kite team deployed improving supply network strengthening partner highly coordinated effort navigate potential supply relationships chain disruptions find alternatives transportation challenges canceled flights border closures pieter van hengel required extra care shipped patients cells supply chain kite manufacturing locations around world monitoring flights tracking hospital capacity working closely authorized treatment centers establishing mitigation plans michael stouten cyrilla khalil tcell manufacturing kite diversifying clinical trials committed eliminating healthcare disparities one way address seeking diverse representation clinical trials starts innovation hiv work seeking institutions investigators within communities aim reach helping ensure representation black people people color women antivirals lgbtq individuals significant demonstration commitment ensuring greater inclusion diversity next generation amid pandemic never wavered dedication hiv prevention clinical trials instituting race ethnicity decadeslong quest innovate people living hiv gender age key performance indicators kpis made significant progress advancing investigational longacting antiviral lenacapavir scientists throughout year worked actively recruit black continued pursue ultimate goal potential cure clinical trial participants studies diseases unconventional year pursued creative paths success hiv covid disproportionately impact black patients today well tomorrow beyond hiv communities communities color last year built expertise viral hepatitis entering also shared results landmark braave study agreement add medicine treat chronic hepatitis delta designed evaluate safety virus hdv condition significant unmet medical need efficacy biktarvy bictegravir emtricitabine tenofovir alafenamide black adults living hiv tariro makadzange alivelu irrinki discovery virology helping transform going distance providing shuttle service prevent delays people living hiv care hiv reduced access clinics physicians due israel like many regions people living hiv missed appointments community covid health safety restrictions impacted avoided public transportation due covid employees israeli hiv community spikes demand people stocked affiliate collaborated advocacy groups hiv clinics create program gilead partnered healthcare workers medicines pandemic began transport people safely medical appointments throughout top reduction flights led challenges programs shuttles logged miles hiv organizations provide continuation remote regions certain parts australia vital services employees found creative ways get medicines destinations including reaching patients globally advancing hiv innovation working charter airlines receive priority shipment medicines given critical nature global partnerships gileads medicines today reach millions people lenacapavir investigational agent received low lowermiddle income countries around world committed fda breakthrough therapy designation treatment continuing find ways increase access work resourcelimited countries hiv highly treatmentexperienced individuals hand delivering packaging supplies contract using variety approaches facilitate disease awareness strategically engage multidrug resistance studied potential manufacturers partners efficiently deliver medicines resourcelimited countries estimated longacting option treatment prevention million people living hiv received gileadbased treatment hiv daily single tablet regimens work well many people living hiv others expressed providing personal protective equipment ppe evolving field visits preference options would allow less frequent support internal external distributors oral dosing injections lenacapavir potentially offers supplies low pandemic spurred new ways working global field teams convenient alternative dosing option people living find innovative ways provide appropriate support global gilead teams shifted stephen mccracken risk hiv seminars online relied strong relationships healthcare providers hiv sales work ensure patient needs met addressing viral hepatitis myr acquisition elevating patient voices announced agreement acquire myr hepcast podcast features individuals completed march adding hepcludex medicine working eliminate hcv developed partnership conditionally approved european commission world hepatitis alliance series goes beyond july treatment chronic hdv hdv health numbers explore human impact hcv severe form viral hepatitis occurring patients episode features someone hcv experiences cary james already hepatitis b virus hbv hepcludex including doctors policymakers community world hepatitis alliance investigational agent safety efficacy advocates listen hepcast established united states regions received regulatory approval elimination efforts transformation set goal eliminating hbv hcv viral hepatitis treatment working toward target supporting efforts governments patient organizations payers worked improve care people viral hepatitis healthcare providers increase awareness drive years medicines hcv offer screening facilitate linkage care since jack boeve left pictured advanced practice potential cure majority people receive registered nurses kristie hack jessica gossom estimated million people hcv also committed providing new better options resourcelimited countries received medicines people hbv continue pursue cure hcv sales growth despite disrupted world kept eyes future continually asking whats next oncology significantly enhanced oncology portfolio important new pillar growth programs gilead seek achieve strategic ambition delivering transformative medicines patients entered acquisitions partnerships oncology adding commercial portfolio clinical pipeline together new programs potential reach patients range hematological malignancies solid tumors impactful partnerships acquisitions gilead entered strategic partnerships acquisitions including oncologyfocused transactions result increased pipeline overall measured asset indication projects direct ownership new molecules right opt molecules opportunities help us accelerate development potential commercialization medicines patients daejin abidoye devang bhuva oncology therapeutics corporate development alliance management qa people powering progress gilead active acquisitions partnerships oncology tell us qa merdad parsey chief medical officer significantly added portfolio complement strength virology immunology cell therapy acquiring approved oncology medicines latestage assets strong data important options impressive number investigational therapies targeting treatment patients people make growing legacy cancer end internal clinicalstage oncology programs focused helping innovation possible dedication patients greatest unmet medical need augmented portfolio external products substantively expand ability make difference cancer focus enable breakthroughs thought impossible dedication programs various stages development number clinical candidates evaluating solid tumors hematological malignancies marketed product trodelvy enable future success gilead brought metastatic triplenegative breast cancer april fda granted accelerated approval talented new hires company last year trodelvy use adult patients locally advanced metastatic urothelial cancer uc addition seek build expertise collaborations external partners access cuttingedge research programs right opt depending future milestones oncology deliver important new medicines patients cancer merdad parsey shares perspective gileads expansion oncology tell us little bit think drives gileads dedication work pieces come together im proud say team brought together deeply committed important work benefit people cancer touched someone cancer either personally family member loved one acquaintance many us similar experiences diseases like covid gilead legacy changing lives people living hiv curing freedom take approach people hcv treating people covid inspires us part changing narrative oncology well bend anchored bring arc means affected cancer thats committed work across many impact continue think benefit areas including oncology many important advances past couple decades much potential treatment bring patients modality needs done thats drives us every day treatment see pipeline ranges antibodydrug conjugates small molecules intentionally building portfolio candidate medicines enable us explore new ways put cell therapy pieces together make difference people fit picture cancer everywhere work closely colleagues kite gilead goal oncology responsible research process development therapeutic areas bring forward medicines clinical development commercialization cell truly innovative offer transformative improvements therapies kite focused getting therapies people hardtotreat conditions look patients earlier course treatment broadening medicines weve advanced internally ones use medicines make difference wider range weve added external acquisitions partnerships conditions advancing new therapies youll see goal driven decisions development process efforts gilead aim build complement cell therapy starting think potential combination treatments seek find innovative ways make difference people cancer growing pipeline portfolio forty seven magrolimab continue enhance clinical pipeline acquisition forty seven inc strengthened gileads external partnerships collaborations oncology research development portfolio addition magrolimab investigational potentially firstin internal research development class anticd monoclonal antibody studying passionately pursue transformative science number hematological cancers potential treat innovative medicine areas virology solid tumors magrolimab received fda breakthrough oncology inflammatory diseases therapy designation treatment newly diagnosed myelodysplastic syndrome immunomedics two car trodelvy therapy offerings acquisition immunomedics inc october added first medicine solid tumors trodelvy july fda approved kites second chimeric firstinclass medicine people metastatic triple antigen receptor car tcell therapy tecartus making negative breast cancer one toughesttotreat forms kite first company two approved cell therapies disease triplenegative breast cancers account yescarta market since tecartus approximately breast cancers gilead exploring treatment adults relapsed refractory mantle cell trodelvys potential treat many types cancer lymphoma form nonhodgkin lymphoma arises monotherapy combination cells originating mantle zone lymph treatments including types breast cancer non node mantle cell lymphoma become highly aggressive small cell lung cancer solid tumor types april patients whose disease returns initial therapy niemel mirza fda granted accelerated approval trodelvy tecartus offers important new treatment option use adults locally advanced metastatic uc patients tcell manufacturing kite expanding global manufacturing network kite received ema approval car tcell manufacturing facility amsterdam june opening site europe provides kite opportunity reduce amount time patients wait receive lifesaving individualized treatments patients receive cell therapies often quite sick timely access therapy critical new facility eliminates steps shipping patients cells california facility back reducing time takes car therapy reach patients almost week european manufacturing facility expected allow us supply treatment additional patients per year outside united states using cell therapy kite solely focused advancing qa cell therapy role cell improve outcomes therapy play treating cancer people cancer car personalized therapy involves engineering patients white blood cells fight cancer cell therapy trains persons immune system recognize attack destroy certain types cancer engineered tcell therapy qa christi shaw among biggest breakthroughs cancer treatment since introduction combination chemotherapy chief executive officer kite years ago remarkable genetic engineering process committed bringing people need kite continued drive innovation help people cancer autonomous organization benefit collaboration cell therapy complement gileads broader work cancer gilead kite continued resolute pursuit cure focusing transformative kite gilead focused lifechanging cancer medicines hardtotreat cancers medicines striving fundamentally change way target difficulttotreat cancers bold vision kite chief executive officer christi one committed achieving together shaw shares update years advancements milestones tecartus received fda approval role helping yescarta continues ensure people access kites deliver promise car therapies impact therapies continue innovate cell therapy bring new therapies patients ensuring hospitals reimbursed proud able bring benefits car car patients able receive regardless people cancer tecartus first receive care crucial applies car tcell therapy patients relapsed refractory todays car also critical bring cell therapy mantle cell lymphoma tends become people different kinds cancer aggressive time data yescarta four years postinfusion trial demonstrated longest patients seen community oncologists term survival results car pivotal trial people essential build kite communityfacing relapsed refractory large bcell lymphoma field force mission team educate physicians benefits car identify reduce barriers may prevent patients accessing treatment authorized treatment center also worked us government broaden access cell therapies patients covered certain government programs kite employees el segundo california section going workforce jack hein alan huang facilities hein engineering huang employees dedicated work life gilead rewarding recognizing leadership commitments vision making world retaining employees healthier place guided leadership commitments describe mindset behaviors strive organization core values accountability excellence gileads compensation benefits programs designed attract cultivate retain industrys inclusion integrity teamwork talented workforce offering competitive packages bold aspiration agile execution include bonuses stock grant opportunities embracing courage aim high explore new ideas also introduced new take risks learn challenge adapt quickly encourage leadership commitments emphasize additional benefits tailored needs outspoken dialogue people various worldwide locations include way work care make time people flexible work arrangements support training important work showing empathy compassion demonstrating respect education paid time family planning benefits creating space feedback supporting achieve disability retirement benefits access something bigger variety health wellbeing resources listen speak openly explain year reassess total rewards package listening carefully speaking embrace opportunities ensure offers right benefits incentives help mutual improvement providing reasons behind us attract retain critical talent decisions trust others make sound decisions moving forward together empowering individuals teams make decisions take new opportunities responsibilities impact words actions lily lei exemplifying gileads core values acknowledging ones marcus mcmillan motivations missteps disagreeing respectfully providing human resources facilities constructive thoughtful feedback gilead invests compensation financial benefits include longterm potential financial benefits gilead sees employees gilead payforperformance company committed pay equity employee salaries based market mia campitelli director public affairs based ranges assessed annually consideration read mias story prioryear performance compensation decisions made without regard personal characteristics gender race color national ethnic origin age disability sexual orientation gender identity expression genetic information religion veteran status conduct annual review employee compensation ensure retirement savings employee stock purchase personalized financial coaches pay practices race genderneutral also matching contributions available program allows eligible gilead united states offer commission annual global pay equity study gain many countries based employees purchase gilead employee consecutive comprehensive view pay parity across organization local market practice stock discount consistent days per year free oneonone regulations internal revenue service financial coaching covering areas requirements managing student loans gilead proud paying debt planning working retirement named mother best gileads salary ratio women companies list men globally mia campitelli pictured daughter public affairs detailed information gileads defined benefit plan obligations see annual report investors website evolution health benefits addition marketcompetitive competitive paid time healthcare wellbeing risk benefits offer help welfare benefits employees families depending gilead offers competitive paid time benefits help employees feel employees country location wellbeing offerings rested balanced employees get companypaid vacation days include biometric screenings health assessment tools continued prioritize holidays well family parental leave benefits vary wellbeing seminars onsite fitness centers annual focus employee health wellbeing country region based local laws regulations market practices fitness reimbursement risk benefits include sick days implemented new global december shutdown gilead introduced range programs disability benefits companypaid life accidental us employees offer fourth july holiday week support employees including help death dismemberment business travel accident robb mcfadden left pictured family insurance people adapt new ways working employee relations united states expanded health global reimbursement welfare benefits include family planning resources global parental leave data females males total united states support employee adoption surrogacy assistance elective wellbeing expenses eggfreezing breast milk delivery service number employees entitled parental leave breastfeeding mothers traveling business related program provides support working parents number employees took parental leave workfromhome support including pregnancy babys first year including doula number employees returned work leave ended additional reimbursement services lactation consultants career coaches create home workspaces parenting specialists also provide fertility support number employees retained months returning work coverage possible varying region following period parental leave number employees took parental leave monthly childcare expense reimbursement behavioral health worklife services parents programs people also access financial legal return work rate preretirement elder care childcare consultations return work rate well clinical counseling retention rate supporting employee assistance professional california wildfires personal development people california home headquarters experienced recordbreaking wildfire season nearly gileads learning development program fosters culture building meaningful million acres burned affecting nearly every region continuous growth helping people develop skills state fires existing crisisresponse systems tools grow careers deepen engagement connections procedures ensured employees safety gileads culture provided support paid time reimbursement gmentor mentoring program one way impacted covid protocols mandated switch virtual formats help earlycareer employees build connections enabled us reach employees past years experienced gilead leaders security operations center thirdparty tool end gilead learning development delivered employees participated gmentor quickly mapped contacted employees living within live remote workshops sponsored facilitation mentee survey respondents reporting areas experiencing significant fire events logged hours training seamlessly converting redesigning strongly satisfied satisfied mentoring responses transmitted responses human content virtual delivery experience saying likely resources hr affected employees received immediate recommend program colleague hr followup assure safety communicate addition taking advantage gileads learning applicable benefits included development curricula employees receive reimbursement tuition expenses incurred pursuing undergraduate emergency thirdparty evacuation services graduate certificate courses accredited college paid disaster recovery leave university annual reimbursement maximums eligibility vary country gilead also supports continuing reimbursement damage education reduced tutition mba programs loss property golden gate university hotels meals employees hafsa khan employees took advantage offering families calendar days sierra andregg regulatory affairs facilities listening grow would recommend gilead kite key insights pulse surveys year showed high engagement employees describing gilead new high company recent surveys innovative ambitious company employee wellbeing priority need continue focus pulse surveys surface diversity improving processes decisionmaking employee sentiment emerged areas improvement listen one companys new leadership strengths commitments organization deeply committed learning employees taking employeedriven approach evolving culture helps ensure people feel heard respected turn promotes higher engagement improved retention employees say employees say heightened innovation helping us recruit industrys speak input feel respected best talent considered formalized listening strategy introducing new approach surveying teams augment existing employee feedback opinions crucial programs believe listening enterprise level helping understand gilead well well focusing regions functions teams improve strive become ensure timely capture employee sentiment especially biotech employer choice achieve pandemic increased frequency corporate ambitions type insight key pulse surveys surveys sample random selection areas improvement part gileads evolution employees around world provide realtime insight whats working well need focus jyoti mehra agree people backgrounds agree work processes making improvements agree people backgrounds agree work processes agree gilead minimizes executive vice president human resources opportunities succeed wellorganized efficient opportunities succeed wellorganized efficient bureaucracy commitment listen first blueprint change racial equity built existing programs introduced new ones gilead launched blueprint change create processes goal deepening commitment racial equity partnerships increase recruitment diverse social justice inside company led chairman candidates blueprint change intended help chief executive officer daniel oday summer increase black latinx workforce building senior leaders worked globe employee relationships hiring diverse talent resource group erg hold series listening sessions universities organizations support current town halls understand concerns black future talent needs employees could use platform promote samuel gonzalez racial equity listening sessions town halls led part blueprint change introduced two new marketing operations creation advancing black leadership strategy programs designed increase representation black provide opportunities existing employees well latinx individuals gilead propel aimed candidates additional programs recruit diverse job candidates less four years relevant experience ignite active leaders midcareer hires experienced professionals diversityfocused recruiting initiatives include investing gilead strives maximize impact local communities development internal career mobility expanding supporting inclusion diversity drives early pipeline diverse talent also announced think diversity inclusion active participation partnerships sales fund scholarships increase recruitment think diversity invited professional development organization national sales efforts historically black colleges universities network hispanic association corporate hbcus well hispanicserving institutions dance think inclusion responsibility equal executive leadership actually asked dance council lead gilead also participates california conference women regulatory valerie brown affairs professionals society diverse leaders senior vice president quality assurance joined leadership andor development programs executive sponsor globe organizations provided part growing learn watch championing possible video commitment diverse talent leadership development driving change opportunity enhanced inclusion diversity training launched two new inclusion diversity learning programs designed augment broader efforts included four selfpaced antiracism elearnings virtual workshop combating bias workplace also expanded inclusive hiring curriculum designed promote equity show bias affect hiring process sevenpart series targets hiring managers advancing multiyear diversity goals set clear internal representation goals well goals related suppliers business also set goals related organizations support corporate giving initiatives without engaging racial preferences using race basis employment decisions quotas jocelyn de la vega committed increasing employee executive representation underrepresented groups increasing transparency data legal belinda moore progress regularly updated prioritized actions managed markets gilead receives gilead proud ecosystem approach rating hrc corporate named among inclusion diversity equality index companies gilead approach inclusion diversity forbes americas best angles focusing people corporate equality index cei human rights campaign foundation named gilead list employers diversity relationships external partners best places work lgbtq equality awarded organizations dedicated societal change list second year company perfect score third consecutive year launched global diversity council led row cei annual national benchmarking tool chairman chief executive officer daniel oday assesses companies policies benefits practices comprising members gilead leadership team erg related lgbtq employees families executive sponsors erg leads mission index also scores companies responsible citizenship council starts listening employees stakeholders public commitment lgbtq equality ensure voices heard determining critical furthering inclusion diversity gilead listenfirst foundation council set provide governance track progress culture inclusion council ensures appropriate goals strategies enables us learn initiatives adapt ensure impact responsibilities also include reviewing approving diversity goals reviewing pay equity identifying trainings bring diverse talent gilead michael jones medical writing gilead employees raise pride flag foster city california deepening accountability representation goals set new representation goals formally tied kpis starting organizational leaders required regularly review update inclusion diversity action plans business area focused attracting developing retaining people diverse backgrounds creating inclusive culture goals achieved include promising employees developing diverse backgrounds received total workforce people managers vp diverse talent female maintain female female specialized development black us black us black us support executive leaders senior vice experiences presidents sponsorship tailored mentoring hispanic us hispanic us hispanic us programs provide access diverse senior leaders sponsorship tailored coaching specialized development experiences mentoring programs formalized executive diversity goals corporate departmental liliana de la paz level take effect formulation process development cultural evolution employee resource groups drive critical action gilead pursues purposeful actions foster inclusion diversity levels company open gilead employees ergs integral part inclusion diversity program focused create sense belonging believe creating diverse workforce makes us five pillars recruiting professional development culture successful innovative organization business impact community ergs key mark dresser middle pictured parents gilead culture hosting events raise cultural awareness organization whole offering members biomarker sciences clinical pharmacology opportunities networking mentoring development demonstrating commitment inclusion diversity requires us leadership skills employees belong encourage recognize consider respect seek support mitigate multiple pathways people diverse perspectives least one six ergs collaborating externally unconcious bias success backgrounds drive innovation experience amplify impact recognize opportunity make changes internally also promote social justice racial equity externally thats work leverage committing principles right thing creating culture influence resources create meaningful impact every individual feels seen heard respected essential helping gilead fulfill across supply chain ecosystem partner mission future organizations dedicated promoting racial equity k steam education higher education diversity hiring leadership development growing global workforce us gender age raceethnicity distribution gileads global workforce grown employees spanning data countries strive close creative collaborative culture employees see tangible results contributions gender raceethnicity engage ongoing development enhance skills hispanic eeocategory male female white black asian latino executives gilead workforce demographics firstmidlevel managers professionals hires total gilead us population new hire rate voluntary turnovers data based us definitionsdemographics eeofiling based december data includes kite category includes two races native hawaiian pacific islander american indian alaskan native categories voluntary turnover rate executives compose less gileads us population make governance bodies comprise vice president levels workplace safety gilead believes safe secure workplace promotes employee health wellness productivity also inspires innovation workplace safety training security program designed prevent occupational injuries illnesses promote culture reporting ensure continued adherence programs policies provide employees annual refresher courses well tailored training sessions also investigate catalog incidents nearmisses worldwide responded covid pandemic new procedures protect workers must onsite including requirements around ppe physical distancing onsite workers also received special pay enhancements kent keilwitz bandita parhy facilities clinical virology frequent workrelated injuries resulted musculoskeletal extremity upper torso strains caused ergonomic hazards individuals affected able recover fully within six months environmental health safety team meets quarterly review environmental safety performance across worldwide sites joint managementline healthandsafety committees review sitelevel performance incidents occur onsite teams complete indepth reviews identify causes determine mitigate risk recurrence safety performance fulltime nonfulltime employees number fatalities result workrelated injury rate fatalities result workrelated injury number highconsequence workrelated injuries rate highconsequence workrelated injuries total number recordable workrelated injuries annual total hours worked rate recordable workrelated injuries edvin reyes number highconsequence workrelated injuries based lost timedays away restricted workday cases reported occupational safety health administration pilot plant section glance delivering innovative medicines critical also right people planet reducing building greenhouse gas ghg emissions minimizing waste generation working toward resource efficiency society seek address climate change means sustainability working find new sustainable ways conduct business gilead committed creating future responsible resilient growth factoring health people communities environment everything resilience environmental data content period boundaries throughout report describe environmental activities initiatives occurred calendar year however environmental reporting data yet finalized verified validated time report published therefore environmental data charts included section cover calendar year january december gilead publish environmental data website becomes available responsible growth strategy environmental challenges also human health center environmental strategy goal challenges need healthy planet healthy reduce ghg emissions across scope direct population effects climate change expected emissions scope emissions generation intensify recognize must continuously energy purchase consume innovate improve environmental performance compared baseline protect collective future committed setting ambitious new goals responsible growth strategy around climate energy laid groundwork bringing together mission environmental setting new carbon targets science based stewardship investing operating business targets initiative sbti align efforts efficiently sustainably working discover paris agreements principal goal limiting global develop commercialize innovative therapeutics temperature rise well c preindustrial worlds serious illnesses corporate levels anticipate receiving sbti approval social responsibility csr committee responsible embedding integrating climate change energy material esg issues overall business strategy operations committee reports board directors least annually management issues buildings sites go green building sector efforts include aligning building projects construction plus ongoing operations green construction standards leadership energy environmental design leed building accounted worlds total research establishment environmental assessment method energyrelated co emissions breeam prioritizing opportunities retrofit existing operate buildings buildings standards leasing space prioritize buildings recognized countries employ sustainability performance able brought people worldwide focus standard gileads internal fitout efforts green construction retrofits leedbreeam equivalent standard represents significant potential co gilead currently manages million square feet facilities reduction worldwide added six new leedcertified buildings one new breeam site growing portfolio open new labs offices partner total facilities either currently certified architects engineers contractors share pursuing green building recognition commitment sustainability green building renovation strategies together focus sourcing continue grow business expect materials responsibly promoting efficiency energy aggregate energy use may increase focus water use improving indoor air quality promote generating procuring renewable energy contribute health wellbeing productivity people lowering total ghg emissions greenhouse gas reduction progress toward goals progress goal center environmental strategy goal gileads emissions remained flat compared scope ghg emissions gilead worldwide operations reduce scope scope ghg emissions despite increase operational footprint reduced compared baseline alignment scope ghg emissions focusing energy efficiency reporting units mt co e paris agreement meet goal increasing renewable energy consumption scope developed multiyear plan includes procuring achieved reduction ghg emissions nearly renewable energy highimpact locations improving halfway goal scope marketbased energy performance facilities scope locationbased efficient technologies practices continue work toward goal continue growing facility footprint responsibly expanded gilead publish scope emissions data website onsite solargenerating capacity larger commitments purchasing renewable energy electrification vehicle goal reduce total ghg emissions fleet see tracking worldwide energy consumption achieved reduction ghg emissions ghg emissions intensity gileads ghg reporting boundary includes facilities reporting units kg co e per million sq ft progress gilead maintained operational control january december previous years scope ghg emissions inventory verified third party co e goal scope marketbased third partys assurance statement available upon request reduction mt coe scope marketbase verification performed limited level assurance scope locationbased emissions using international organization standardization iso verification standard ghg assertions currently developing ghg emissions inventory calendar compared baseline year following thirdparty verification currently developing ghg emissions inventory calendar year following third inventory made public website party verification inventory made public website environmental impact across operations leaving behind typical take make waste manufacturing model embracing reduction ethos efficiency resource conservation waste reduction means gathering insight environmental impacts facilities level continuously monitor building business lifecycle sourcing raw materials energy use identify opportunities implement efficiency manufacturing medicines global distribution solutions benefitting sustainability goals disposition postconsumer waste process allows us operating costs apply evolving best practices emerging technologies drive sustainable practices despite unanticipated challenges due covid pandemic continued make great strides global sustainability committee oversees effort efforts particularly advancing green chemistry representatives gilead kite facilities alternatives keeping active pharmaceutical compounds regularly sharing best practices promote consistent environment expand manufacturing sustainability approaches across operating regions supply chains globally committed committee reports progress csr committee socially environmentally responsible manner advancing green chemistry success reducing veklurys pmi brought us significant sustainability benefits gilead use green chemistry principles early enabled us produce faster drug development manufacturing deliver impact using cleaner safer materials reduces environmental ensure continued focus green chemistry practices impacts cuts costs boosts efficiency bringing took initial steps toward labs certified green lab medicines people nonprofit organization established considered global standard laboratory sustainability best practices team process chemistry professionals foster city facility gileads site edmonton lead ongoing green chemistry efforts leveraging research expertise well learnings gileads wideranging participation american chemical societys green chemistry institute roundtable groups team members evaluate new ideas present alternative processes making positive areas chemical versus biocatalysis use sustainable impact greener solvents employees think sustainability daytoday research decision making able deepen pool resources chemical process optimization efforts allowed us process optimization available us sustainability journey improve pmi scores veklury biktarvy improving efficiency cutting total mass solvents reagents reactants operations manufacturing consumables employed across product life cycle bringing new medicines market respectively boosting availability patients around world pharmaceuticals tracking worldwide environment energy consumption gilead committed preventing active pharmaceutical expand manufacturing deliver medicines increased ability generate renewable compounds contaminating environment people energy use naturally increase challenge energy initiating new solar installations research development manufacturing facilities meet increased demand leveraging renewable foster city la verne oceanside california uphold strict operational standards processes energy operational efficiencies reduce carbon combined three installations expected wastewater discharge solid waste disposal mitigate footprint risks discharge generate million kilowatthour kwh tracking total corporate energy use nonrenewable per year clean power netherlands work pharmaceutical product renewable sources energy use intensity kites new manufacturing facility fully stewardship work groups medproject gilead helps individual sites able generate comprehensive electric supplies electricity prevent environmental contamination resulting view gileads energy consumption informs global improper consumer disposal expired unneeded energy management strategy allows us evaluate renewable sources solar wind medicines sharps including needles syringes efficiency site site facilities portfolio grows rooftop solar panels design maximizes people california washington massachusetts natural light combined powerpurchase dropped metric tons materials via total energy consumption rose agreements renewable energy community kiosks gilead supports project compared renewable sources accounted innovations allow facility achieve net zero annual contributions totaled total total renewable energy consumption increasing ninefold since co emissions exploring increasing solar capacity sites real estate portfolio total area facilities worldwide operational control millions sq ft critical need worldwide energy consumption intensity water management energy consumption mwh energy use intensity kwhsq ft facing longterm water shortages symptoms prolonged water stress home state california many operating regions increased focus water conservation total energy consumption renewable sources installed new watersaving technologies identified conservation efforts increase water efficiency current systems total energy consumption nonrenewable sources facility cork pilot program install waterless urinals saved liters water gallons course total combined energy consumption year expansion program across facility expected produce water savings million liters gallons figure includes renewable energy purchased grid renewable energy procured sources retrofitting greater energy efficiency worldwide water usage facilitate maximum energy efficiency across real estate portfolio continuing program retrocommissioning older gilead buildings higher environmental standards providing sustainability benefits foreseeable future began pursuing leed certification central hub foster city campus moscow business center obtained water source megaliters megaliters megaliters first breeam certification commercial interiors indoor use also investing targeted efficiency upgrades conservation strategies assessments upgrades facilities around world led reductions energy consumption foster city optimization strategy office duct static irrigation reset able save combined million kwh almost k therms oceanside improved efficiency exhaust systems replacing old fans installing new variablespeed hvac motors reducing air exchange rates firelife safety na hours edmonton cork facilities reduced energy consumption implementing new powerdown strategy total water usage nonoccupied hours together efforts generated projected annual savings kwh k therms worldwide waste disposal waste reduction recycling nonhazardous waste disposal metric tons businessled employeedriven recycling reduction initiatives helped landfill reduce waste core element corporate sustainability plan composting recyclables continuing make progress waste expanding lab glove recycling program gilead alberta recycled incineration data collection sites sites pounds nitrile gloves one calendar quarter covid reduced onsite recycled gloves used manufacturing na na workforce wastereduction programs secondary deck chairs plant pots two seen total focus though new wastereduction plans put employee lunch patio place number sites anticipation future fullstaff return facilities foster city cambridge cork hazardous waste disposal metric tons dublin santa monica seattle stockley park system centralized trash collection improved segregation deep well injection recyclables helped shrink wastetolandfill rate incineration oceanside site initiated food scraps composting program incineration energy recovery landfill na neutralization onsite storage na na na recovery reuse recycling business resiliency business resiliency vital gileads continued time business depends securing steady supply raw materials need create products impact global health continually monitor assure resilient supply chain focused growing mitigate range environmental supply supplier base prioritizing small diverse suppliers chain ethical risks ensure leverage broadbased perspectives spur innovation adapt quickly potential disruptions ensuring partners share environmental ethical commitments throughout pandemic headquarters california recordbreaking able maintain ample supply active pharmaceutical fire season gave us particularly clear view ingredients due strategy leveraged geographic climate crisis effects skies filled smoke diversification asia north america european union droughts continued threaten water security strategic inventory management agriculture heat waves impaired peoples health productivity importance addressing climate also work sustain integrity products issues emphasized upholding highest standards drug safety exercising transparent labeling marketing practices taking measures eliminate distribution counterfeit medicines susan pepper corporate sustainability health safety encounter actual potential violations longterm view working suppliers company policies governing regulations recommend climate risks share values corrective action flag supplier followup evaluations certain violations environmental negligence human trafficking use forced labor recognizing growing relevance climate change business resiliency completed gileads supply chain includes hundreds direct would prompt gilead terminate agreement assessment entire real estate portfolio better understand climaterelated risks suppliers thousands indirect suppliers supplying organization remove supply chain sites potentially vulnerable included following risk categories assessment across globe referenced supplier code conduct scoc across supply chain oppose condemn following practices use child labor forced labor acute physical risks chronic physical risks human trafficking unfair treatment wagesbenefits eventdriven risks including severe storms wildfires risks related longterm shifts climate patterns unreasonable working hours discrimination based floods droughts including sealevel rise chronic heat waves race color gender religion disability sexual orientation gender identityexpression also support full compliance applicable legislation including uk modern contextual risks transitional risks slavery act risks related ability plan implement risks associated shift toward lowcarbon continued working toward goal securing adaptive strategies reduce vulnerability moderate economy including compliance new carbon signatures direct indirect suppliers potential damage regulations based spend scoc outputs included ranking sites based composite risk profiles built monitor supply chain continuously adequate capacity diversification potential risks adherence work using scenario analysis better understand potential risks selected business gilead policies governing regulations critical sites higher risk profiles using results analysis reviewing risk mitigation us foreign corrupt practices act fcpa us plans working estimate potential financial impacts trafficking victims protection act applicable labor environmental regulations addition programs advocate responsible supporting inclusive supplier inclusion throughout healthcare sourcing program highperforming supply general procurement spaces aligning industry councils authoring thoughtleadership articles partners industryfocused publications continued secure highest quality raw materials partnerships supplier diversity pharmaceutical products assure sustainability human rights inclusion one core values extends forum western regional minority supplier commitments extend throughout supplier ecosystem work external partners vision become development council build capacity grow enforce rigorous supplier vetting process industry leader supplier inclusion integral part relationships new inclusive suppliers launched threeyear responsible sourcing strategic gileads diversity efforts plan identify partners share commitments environmental performance health safety inclusion taken measures drive supplier inclusion across diversity human labor rights anticorruption risk procurement processes procedures creating management auditing criteria inclusion targets supply chain challenging increase overall spend small diverse resposible sourcing working group began suppliers gilead spent million small pilot program address ghg emissions reductions within diverse businesses set goal increase responsible sourcing strategy effort began also created implemented supplier suppliers representing total annual spend inclusion champions program ensure sustained focus supplier diversity modeled scope purchased goods services co e emissions goal reduce scope prioritizing relationships businesses owned emissions years compared base year women people color veterans members plan start engaging suppliers lgbtq communities continue realize purpose representing scope purchased goods every transaction make prioritizing services ghg emissions spending small suppliers benefit stephanie berger greater agility quicker response times stabilize gilead supplier supply base gilead adheres strict product safety labeling safety marketing data security anticounterfeiting guidelines products undergo rigorous ethics development testing clinical trials use labeling marketing practices comply governing policies regulations gilead transparency receive warnings fines penalties government body related marketing labeling practices use combination inhouse technology thirdparty security services systems protect personal data comply european union general data protection regulation data protection regulations gilead substantiated complaints concerning losses customer data safeguard patient safety anticounterfeiting team consists brand protection legal security supply chain quality packaging professionals uses range measures deter detect block report sales counterfeit diverted medicines noy phengrasamy corporate sustainability health safety section elevating impact society hellenic liver patients association prometheus gilead cares grantee giving gilead committed removing gilead provided barriers healthcare corporate million giving programs fund work eliminate back health disparities underresourced cash donations organizations communities around world goal addressing community need communities overcoming social economic obstacles areas covid health health improving peoples lives racial equity wildfire relief partner patients communities build collaborative solutions extend access lgbtq support care broadly possible efforts focused acutely covid pandemic well supporting communities disproportionately impacted diseases aligned therapeutic focus areas advancing education supporting local communities facilities located igor harley henriques hiv community advocate almaty kazakhstan fundo positivo gilead grantee access medicines hepconnect reaching crucial keep educating communities pro bono team currently composed approximately employees including lawyers colleagues acting ensure conversations occur around world people live translators administrative assistants others patty whether thats text messages thayer vice president legal works kids need gilead works public health officials community past years us opioid crisis caused social media platforms doesnt matter defense kind organizations represent advocates researchers doctors patients carry sharp jump hcv diagnoses appalachian region reach people matters refugee immigrant minors seeking legal status programs provide access medicines low united states us centers disease control united states often fleeing violence abuse middleincome countries apply variety approaches prevention cdc reporting increase central abandonment neglect central america senior including appalachia gileads hepconnect associate general counsel joel silver works frequently works local organizations indiana kentucky north thomas gooch legal aid society san mateo county representing tiered pricing discounts medicines based carolina tennessee west virginia expand screenings prevention director survivors domestic violence disease burden national percapita income linkage care support harm reduction community street works nashville tenn education build knowledge resources capacity hepconnect grantee patty kind advocate year award communities need greatest work joel past recipient california bar responsible licensing generic versions products associations corporate pro bono award enable highquality lowcost versions hiv viral since inception hepconnect grantees hepatitis medicines low middleincome countries reached individuals distributed million harm reduction kits throughout initiatives advocacy public health initiatives policies target states also prioritizing outreach people pro bono team aids believe duty privilege maximize patient reach prevent new serious color services filling organizational vacancies lawyer recognize everyone illnesses help destigmatize diseases immigrants domestic innovating response covid hepconnect grantees afford lawyers everybody needs deployed telehealth programs offered mobile care violence survivors strengthening health systems bolster diagnostic vulnerable clients gilead support hepconnect grantee lawyers treatment surveillance capacity organizations experiencing covidrelated financial gileads pro bono legal program provides vital counsel challenges able access rapidresponse people communities afford legal services patty thayer collaborative research targets innovative therapies funding national harm reduction coalition program gives employees chance make vice president legal informs drug delivery helps countries map disease meaningful difference people need burdens employees partnered giving together giving together efforts including support employees communitybased covid relief supporting global organizations direct charitable work giving together program relief international medical corps united nations headquarters san francisco matches employee donations eligible nonprofit foundation bay area committed ensuring organizations giving together also matches students live communities near employee volunteer hours reward points gilead campus tools need sent donations qualifying nonprofits pride month giving together campaign supporting attend school virtually said kate wilson employees choosing rewards organizations focused working toward civil justice senior director corporate giving gilead fighting police brutality including peoples institute earned part gilead volunteer campaigns survival beyond undoing racism brave space equity education fundamental toward independent volunteer work alliance showing racial justice achieving health economic social equity tech exchange oaklandundivided campaign covid giving california wildfire relief supporting statewide relief organizations including california community foundation together campaign southern california wildfire relief fund napa valley community foundation community foundation santa raised support k athome learning cruz county california fire foundation employees learning shifted online children around world lack home computers internet access left many children unable fully participate distancelearning donated veterans day giving together campaign supporting fisher house foundation operation care comfort san francisco bay area gilead donated oaklands oaklandundivided bridging gap veterans inc work house campaign streetcode academys level initiative east palo alto support military veterans families support educational efforts provide k students computers wifi hotspots communitybuilding programs covid gilead cares supporting communities covid support helps recognizing pandemic created significant challenges many nonprofit organizations gilead funds announced creation gilead cares covid acute relief emergency support philanthropic fund april cares provided million direct cash payments plus additional matching grants organizations worldwide fill unmet needs million current gilead nonprofit grantees facing million san mateo county strong fund closure termination vital services due pandemic fund provides financial support individuals small attributable losses approximately half fund businesses nonprofit organizations san mateo committed supporting organizations working hiv county california gilead headquartered lgbtq issues including los angeles lgbt center san francisco aids foundation national center lesbian rights trevor project million mayors fund los angeles provides crisis intervention suicide prevention providing support relief pandemic services lgbtq youth recipients included families small businesses healthcare workers checkpoint sofia bulgaria hellenic liver patients others los angeles area kite association prometheus greece provide headquartered services patients viral hepatitis matching funds employee donations global relief organizations imanu rupertgordon national center lesbian rights gilead cares granteesupport racial justice initial roster grantee organizations includes racial equity community impact fund black men metropolitan houston arkansas regional innovation hub bold black organizing leadership dignity december gilead launched racial equity community advocacy mobilization groups byp black youth project community impact fund support highimpact organize mobilize communities join quest east oakland youth development center boys girls clubs greater washington organizations working tackle racial inequities affecting racial equity social justice working toward equitable gilead racial equity community impact fund grantee center racial justice education black communities across united states fund distribution resources black communities initially provide million grants organizations claflin university threeyear period program support eoydc east oakland youth development center gileads investment east oakland youth organizations focused three key areas equity alliance social justice hbcus organizations training development center means families grantmakers girls color next generation black leaders access capacitybuilding programs harlem childrens zone provide support prepare youth young adults horatio williams foundation employment higher education leadership marsha p johnson institute opportunities kinds programs provide educational innovation institutions focused morehouse college traumainformed care approaches desperately providing educational advancement cradleto shaw university needed oakland days seek career development services black students young southerners new ground song combat social injustice achieve racial equity professionals families spelman college community one family time grateful tougaloo college gilead support partnership ubuntu inc boys girls clubs greater washington xavier university louisiana regina jackson gilead racial equity community impact fund grantee president chief executive officer east oakland youth development center partnering study covid health inequities achieving internal gilead provided initial million grant funding external aims mammoth satcher health leadership institute morehouse school medicine support development comprehensive undertaking gilead health equity data platform help address impact covid diseases black community significant role play communities color undoing harmful collecting studying demographic disparities effects racial injustice comorbidities associated covid including honor chance diabetes asthma depression work help inform actionable evidencebased policy changes attain work alongside brilliant health equity ensure disproportionately impacted communities receive resources support gileads grant people gilead also funded creation new black health equity gilead best make alliance composed national thought leaders community daniel dawes representatives scholars researchers policymakers transformative change help coordinate covid education training satcher health leadership institute morehouse school medicine information exchange dissemination policy gilead grantee analysis douglas brooks vice president advancing black equity community engagement public affairs ongoing lgbtq support transcend community able address social impact fund determinants include housing employment access education gilead transcend community access healthcare impact fund supports transled things help prevent hiv organizations working improve community safety health wellness transgender community bamby salcedo founder translatin coalition transcend approved twoyear grants totaling gilead transcend grantee million supporting organizations areas strategic program development capacitybuilding direct service initiatives leveraging community engagement build sustain progress reducing hiv impacts transgender communities transgender people disproportionately impacted hiv jevon martin diagnosis rate three times us national average princess janae place nearly half us transgender hiv diagnoses occur gilead transcend grantee southern united states never thought lifetime id housed atlanta displayed cities around north america years followed two pandemics something quilt continued grow ultimately consisting spend time making masks panels dedicated thats really individuals died aidsrelated illnesses help gilead continued decades support longstanding partner national aids memorial gert mcmullin furthering work educate inspire new quilt conservator national aids memorial generation advocates fight end epidemic also sponsored rd international aids conference went virtual july million donation gilead enabled national aids memorial bring quilt home san francisco maintained repaired san francisco alone people managed team conservators led gert aids memorial quilt returns died aids ive heard many mcmullin quilt project since people say happy san francisco earliest days part national aids memorials quilt national aids memorial effort panels quilt viewed interactive online exhibit golden gate park going peak years hiv epidemic united states san francisco activist cleve jones first conceived able visit quilt see aids memorial quilt remembrance panel made partner child died disease visible reminder friend neighbor devastating impact quilt displayed first time national mall washington dc october covered space larger football field cleve jones included panels founder aids memorial quilt addressing gilead glaad study hiv radian addresses hiv stigma united states eastern europe central asia hiv gilead lgbtq media advocacy radian initiative launched gilead elton john aids foundation addresses new hiv diagnoses deaths hivrelated illnesses eastern europe central asia region seen rise new hiv diagnoses past organization glaad released first state hiv communities decade versus decline globally jump aidsrelated deaths past years stigma study national survey measuring us attitudes toward hiv people living hiv survey found despite significant overall progress providing focused investment million five unfortunately medical organizations years radian comprises two key elements treatments transmission rates stigma misinformation people hiv often apply model cities program helps heavily impacted cities around hiv remain widespread people surveyed services cases discrimination improve hiv outcomes working local organizations unaware hiv medical condition address stigma boost access innovation still common people hiv also face treated harbor feelings discomfort fear strengthen healthcare infrastructure care models people living hiv discrimination among law enforcement unmet need fund supports impactful initiatives agencies radian model cities across eastern europe central asia focusing hiv survey confirms need significant public program aims prevent cases prevention care education community empowerment education efforts help eliminate hiv stigma novel partnerships hopeful change increase knowledge tool driving transmission rates situation almaty radian officially launched first model cities program almaty kazakhstan hiv prevalence almost twice national average partnering six local yelena rastokina organizations radian helping develop costeffective community mobilization scalable model ensure access prevention testing advocacy specialist care citys people particularly vulnerable communities despite home countrys gileads work population southern united states accounts coordinating centers direct new hiv diagnoses country related engagement partners region deaths according cdc addressing epidemic complex challenge requires variety community company provided million based solutions funding southern united states since programs inception support working three partners southern aids coalition university houston graduate college social work nearly organizations emory universitys rollins school public health compass initiative supports organizations provide solutions focusing three approaches pozitivepositive capacitybuilding knowledgesharing providing preventing hiv resources help organizations effective gilead compass grantee atrisk populations scalable ongoing effort gilead providing million wellbeing mental health traumainformed care free bottles hiv prevention medication annually supporting organizations address impact mental cdc provides medication cost illness trauma individuals united states risk hiv lack insurance coverage paired greatly accelerated awareness education antistigma campaigns outreach efforts donations playing important role supporting efforts change public perception hiv helping reduce transmission rates particularly parts combat stigmas people living hiv country highest burden disease gileads compass initiative year million partnership communitybased organizations working address hiv epidemic southern united states gileads commitment cdc extends gilead awards scholarships international aids conference gilead awarded scholarships hiv community advocates attend rd international aids conference offering scholarships group advocates able access latest hiv research science policy including data intersection covid hiv take advantage opportunity network hiv scientists policy specialists community leaders working project open hand advance response around world gilead hiv age positively grantee scholarship gave opportunity learn bring community aging hiv time covid stay abreast current events half people living hiv united states going field hiv everything within years number expected climb survey healthhiv experienced conference shows people aging hiv struggle isolation depression lack brought back community social support gileads hiv age positively initiative designed improve care outreach jasmine davis growing older hiv pledged million grants crescentcare transgender law center support healthcare organizations advocacy groups working address rd international aids conference scholarship recipient stigma loneliness better coordination care people aging hiv gilead focused programs address stigma expand mental healthcare raise awareness unique health needs people living aging hiv section appendix dorothee saddier axe immunooncology aabboouutt ggiilleeaadd governing principles gilead sciences inc biopharmaceutical company pursued achieved breakthroughs medicine three decades goal creating gilead driven science dedicated improving board four committees audit committee healthier world people company committed patient care adhere highest legal ethical compensation talent committee nominating advancing innovative medicines prevent treat standards business conduct protect patient safety corporate governance committee science lifethreatening diseases including hiv viral hepatitis company employees committee board guidelines committee charters cancer found investors website listing gileads board directors board serves stockholders rules require majority members public overseeing management business companys board directors qualify independent headquartered foster city board leadership team employees gilead december board members california gilead employed responsible compliance various business independent board committees composed conduct corporate policies upholding core independent members fulltime employees values integrity inclusion teamwork excellence engaged temporaryagency accountability workers countries six continents individuals employed engaged agency worker third party temporary agency compensated perform work gilead predefined timeframe code stand approach csr gileads governance bodies employees must assess adequacy key corporate policies ensure continue execute mission cfo organization commercial manufacturing comply code ethics antibribery anti annually help ensure consistent current future reducing social environmental impacts managementled committee responsible reviewing corruption abac policy publicly available regulations good governance practices resulting business activities built csr making decisions csrrelated strategies investors website corporate program focuses patients society planet stakeholder engagement reporting risk mitigation policies also available gnet company intranet business relevant activities gilead subsidiaries products distributed throughout world gilead accessible managers employees nominating corporate governance committee affiliates entities acting behalf required additional abac trainings provided audit board reviews oversees csr program comply us fcpa uk bribery act take precautionary approach managing social committee subset board regional applicable anticorruption laws gilead offers training environmental activities minimize potential harm business partners distributors located europe asia materials employees relevant individuals threat objective reduce climate change africa north america south america organizations communicate gileads prohibition impacts foster better communities attract retain top corrupt unethical activity tier employees mitigate supplychain risks prepare success gileads code ethics depends future regulatory changes employee compliance relevant laws rules gilead performs internal external audits monitor regulations associated employment including compliance regulatory company policies csr committee shepherds vision builds laws prohibiting insider trading formal gilead performed approximately audits financial accountability driving positive social environmental mechanisms place address employee concerns around fcpa compliance across roughly countries change across company supply chain composed potential violations gileads code ethics see section leaders public affairs human resources legal code ethics material topics access availability medicines materiality employee recruitment development retention product quality affordability pricing safety corporate corruption governance bribery sustainability materiality assessment business public health leaders across company selected following clinical trial climate change material topics csr program based level occupational health conduct intellectual energy safety property employee gileads internal external influence relative impact wellness pollution innovation diversity peer evaluations due diligence effluents technologies inclusion data privacy fair working security rd unmet conditions medical needs assessing relevant meaningful disclosures employee engagement measure progress plan enhance coverage counterfeit culture illicit trade topics including management approach manufacturing waste supply chain future reporting water packaging management stewardship health system strengthening tax fair philanthropy contribution community society relations health education materials prevention sourcing use increasing importance gilead perspective impact business evitcepsrep redlohekats nrecnoc redlohekats fo eerged ecnatropmi gnisaercni esg categories environmental social governance csr management external stakeholders stakeholder engagement includes groups across following four categories materiality gilead uses companywide management approach continuously monitors operations reduce potential investors rulemakers actual negative material impacts internal external risk assessors watchdogs business leaders direct oversight topic area responsible managing impacts internal bankers insurers global ngos external stakeholders conduct annual evaluations csr ratings indicies regulators management approach year identify strengths areas improvement institutional investors analysts academic institutions stockholders media internal stakeholders industry associations natasha crellin julie di paolo review sustainabilityrelated topics assembled inflammation biology crellin research external innovation di paolo team internal stakeholders across gilead representing corporate communications corporate customer peers contributions access operations emerging markets community business partners pharmaceutical development manufacturing global commercial commercial process optimization healthcare providers partners environmental health safety facilities human insurance providers peers resources legal tax investor relations regulatory affairs patients suppliers communities generic drug manufacturing approach strategy guides approach tax compliance committed paying fair share tax seek comply applicable laws rules regulations meeting tax compliance reporting responsibilities accordingly pay variety taxes including corporate tax income taxes customs duties excise taxes stamp duties employment business taxes jurisdictions required local law also withhold pay employee taxes indirect taxes value added tax strategy also guides approach tax planning analyze potential tax implications ensure clarity global tax strategy line gileads business tax consequences locations operate order ensure compliance business alignment general framework maintaining low risk tolerance level countries operate strategy focuses tax governance control risk management ensuring appropriate levels governance risk management management establishes maintains robust internal tax processes procedures designed mitigate accountability controls govern tax policies financial reporting material tax risks material tax planning proposals procedures including management associated risks discussed approved executive management system key tax processes reviewed chief financial officer board audit committee complying tax laws responsible manner internal external auditors adherence chief appropriate seek high quality external advice financial officer board audit committee receive tax consequences business transactions updates least quarterly basis open constructive conversations moreover gilead employees responsible stakeholders including governments despite strong governance level risk associated upholding gileads core values employees receive tax authorities tax compliance naturally exists tax law training gileads core values code ethics inherently complex result variety includes specific reporting procedures suspected interpretations respect operations violations taxed monitor proposals changes tax incentives stakeholder engagement tax jurisdictional data regulations countries operate order management concerns assess impact business time time following charts prepared provide transparency insight gileads tax profile numbers figures gilead may collaborate taxpayer advocacy groups related tax follow gileads accounting policy outlined annual report note organization summary ensure gileads views considered public significant accounting policies tax jurisdictional data determined based activities gileads subsidiaries tax discourse also support initiatives increase public trust engage tax authorities honesty integrity resident said jurisdiction transparency national international tax regimes respect fairness spirit cooperative tax incurred type tax incurred jurisdiction compliance tax positions filings subject review audit tax authorities jurisdictions conduct business course review strive taxes united states transparent tax authorities providing relevant facts documentation support tax positions property taxes resolve disputes constructively timely manner rest world current future past tax risks industry specific taxes appropriate also seek proactively engage tax authorities interpretation local tax laws payroll tax application specific facts circumstances income tax new tax laws regulations often bring uncertainty interpretation application inconsistent treatment transaction different jurisdictions brings risk charts detail billion taxes gilead incurred income may taxed two tax authorities situations also seek work tax authorities chart left details taxes incurred type tax chart right details taxes incurred jurisdiction transparent manner mitigate possible prevent carisia lloyd highlights gilead pays significant amount tax beyond significant proportion gileads taxes paid united doubletaxation economic profits compliance corporate income tax addition payroll taxes states gileads headquarters majority legal indirect taxes gilead incurred significant amounts industry research development jobs located tax treaties applicable national legislation specific taxes us branded prescription drug fee revenue jurisdiction operation profit jurisdiction fixed assets jurisdiction employees jurisdiction united states rest world charts indicate key gilead metrics jurisdiction gilead primarily earns revenue profit united states assets employees generate financial metrics also predominately located united states silvia miliani reflective gileads tax policy whereby profits aligned assets functions risks associated jurisdiction human resources priority united nations sustainable development goals un sdgs priority un sdgs displayed un sdg icons also used gri content index highlight areas work corresponds specific goals additional information alignment work un sdgs found gri content index report good health wellbeing industry innovation infrastructure expand access innovative therapeutics improve leverage science innovation develop industry human health worldwide aim help end epidemics leading therapeutics areas unmet medical need aids hepatitis combat communicable diseases tony gomez stephanie reloba quality education reduced inequalities regulatory affairs pharmacovigilance epidemiology educate train healthcare providers advanced formed diversity council enhance inclusion therapies especially resourcelimited countries diversity initiatives worldwide gender equality responsible consumption production cultivate inclusive diverse workforce celebrates use green sustainable chemistry possible differences race age gender sexual orientation gender produce therapies benefit human health minimizing identity thinking style environmental impact clean water sanitation climate action protect waterdependent ecosystems using natural committed reducing greenhouse gas emissions bioswales water conservation measures compared levels affordable clean energy partnerships goals generate purchase renewable energy offset forge internal external partnerships improve patient gridsupplied energy worldwide facilities care strengthen health systems reduce social environmental impacts stephanie cox jeremy ohanlon clinical virology corporate developmentdisclosure number disclosure title response un sdg ungc gri content index red link report blue link website strategy statement senior decisionmaker letter chairman ceo daniel oday ethics integrity disclosure number disclosure title response un sdg ungc organizational profile values principles standards code stand norms behavior name organization gilead sciences mechanisms advice concerns activities brands products gilead ethics code stand complete list medicines services found website governance location headquarters foster city ca governing principles governance structure location operations gilead approach csr ownership legal form gilead sciences inc publicly traded delaware corporation delegating authority approach csr prescription products publicly available customers executivelevel responsibility economic markets served africa asia australia europe middle east north america approach csr environmental social topics south america scale organization behind work governing principles financial highlights gilead composition highest governance report select information board body committees directors website board members three identify female gilead growing global workforce information employees track employees contract type workers breakdown available gender region information nominating selecting highest nominating corporate governance governance body committee charter available stakeholder engagement supply chain working suppliers share values anig dn ii tfi sc sa un pt pch lya cn hg ae n organization tracking worldwide energy consumption list stakeholder groups en xt te er rn na al ls st ta ak ke eh ho old lde er rs precautionary principle approach approach csr gilead employees austria belgium brazil spain france collective bargaining agreements italy worldwide workforce subject collective bargaining agreements full list external frameworks gilead aligned external initiatives available website identifying selecting stakeholders csr management stakeholder engagement materiality membership associations gilead member many industry associations including approach stakeholder engagement csr management stakeholder engagement materiality following american chemical societys green chemistry institute roundtable pharmaceutical product stewardship work group supplier diversity pharmaceutical forum western regional key topics concerns raised csr management stakeholder engagement materiality minority supplier development council disclosure number disclosure title response un sdg ungc disclosure number disclosure title response un sdg ungc reporting practice economic performance entities included consolidated financial report direct economic value generated financial highlights statements distributed governing principles defining report content topic report content period boundary defined benefit plan obligations deferred compensation annual report pg boundaries retirement plans list material topics materiality procurement practices restatements information minor adjustments made environmental data proportion spending local suppliers gilead spent annual procurement spend previously reported gileads year review california local suppliers gileads significant location impacted reported progress toward ghg reduction operation headquarters foster city ca goal adjustments due improved alignment data large presence california instance estimation methodologies across reporting define local supplier identified company periods reverification ghg inventories years headquarters located state california retroactive integration environmental data business entities acquired gilead periods corrections anticorruption discrepancies identified publication year review data contained report operations assessed risks related gilead performs internal external audits monitor collected using robust systems tools available corruption compliance regulatory company policies reporting period gilead performed approximately audits roughly countries financial us foreign corrupt practices act changes reporting report fcpa compliance gilead disclose significant risks related corruption identified fcpa compliance reporting period report content period boundary audits specific legal prohibitions date recent report gileads year review published may communication training code stand reporting cycle annual anticorruption policies procedures contact point questions regarding korab zuka vice president public affairs confirmed incidents corruption findings corruption anticompetitive report csrgileadcom actions taken behavior violations antitrust monopoly legislation healthcare compliance violations government body claims reporting accordance report prepared accordance gri gri standards standards core option anticompetitive behavior gri content index gri content index legal actions anticompetitive behavior code stand external assurance copy thirdparty assurance statement obtained antitrust monopoly practices findings corruption anticompetitive emailing sustainabilitygileadcom behavior violations antitrust monopoly legislation healthcare compliance violations government body management approach tax explanation material topic creating better healthier world boundary governing principles approach tax including tax strategy approach tax oversight tax strategy management approach creating better healthier world components governing principles governance body executivelevel tax governance control risk managment position within organization accountable evaluation management approach creating better healthier world compliance tax strategy governing principles disclosure number disclosure title response un sdg ungc disclosure number disclosure title response un sdg ungc stakeholder engagement stakeholder engagement management ghg emissions intensity progress toward goal management stakeholder concerns concerns related tax related tax reduction ghg emissions progress toward goal emissions ozonedepleting gilead currently track ozonedepleting countrybycountry reporting tax jurisdictional data substances ods substances may future related tax effluents waste environmental disclosures management significant waste reduction recycling management approach wasterelated impacts explanation material topic responsible growth strategy waste diverted disposal worldwide waste disposal boundary environmental impact reduction waste directed waste disposal worldwide waste disposal management approach responsible growth strategy supplier environmental assessment components environmental impact reduction new suppliers screened using working suppliers share values environmental criteria evaluation management approach building sustainability resilience responsible growth strategy environmental impact reduction social disclosures energy management approach energy consumption within worldwide energy consumption intensity explanation material topic life gilead organization boundary energy consumption outside gilead currently track energy management approach life gilead components organization consumption outside organization may future evaluation management life gilead approach energy intensity tracking worldwide energy consumption employment reduction energy consumption gilead currently track reductions energy consumption directly related efficiency new employee hires employee gilead workforce demographics initiatives turnover gilead currently track report new hires turnover age gender region information available water effluents water withdrawal worldwide water usage benefits provided fulltime employees rewarding recognizing retaining employees provided temporary gilead provides comprehensive companypaid benefits parttime employees package including health dental vision life insurance emissions longterm disability insurance plans along option participate employee stock purchase plan direct scope ghg emissions progress toward goal k plan fulltime employees working hours unless otherwise specified eligible benefits energy indirect scope ghg emissions progress toward goal indirect scope ghg emissions sustainability performance parental leave global parental leave data disclosure number disclosure title response un sdg ungc disclosure number disclosure title response un sdg ungc occupational health safety nondiscrimination occupational health safety workplace safety incidents discrimination corrective gilead tracks incidents discrimination corrective management system actions taken actions taken however publicly report due employee privacy concerns pending legal occupational health services gilead employees access licensed regulatory actions information subject specific occupational health services ohs working confidentiality constraints hours able arrange transportation ohs locations ohs providers converse official child labor country language ohs gilead comply privacy laws local requirements protecting operations suppliers significant risk working suppliers share values personal health information incidents child labor worker training occupational workplace safety forced compulsory labor health safety gilead uses hazards exposure assessments identify general specific ohs trainings ensure operations suppliers significant risk working suppliers share values training content aligns regulatory standards incidents forced compulsory labor trainers meet local competency requirements trainings provided free charge paid local communities working hours operations local community giving back communities workrelated injuries safety performance engagement impact assessments global employees offered one paid day development programs volunteer organization choice training education covid began spreading across globe winter gilead introduced worldwide policy enabling average hours training per year professional personal development employees medical backgrounds take four weeks per employee gileads employees participate average hours paid time volunteering pandemic response professional training per year currently track investments training specifically gender employee category information available supplier social assessment new suppliers screened working suppliers share values percentage employees receiving gilead employees receive annual using social criteria regular performance career performance career development reviews development reviews customer health safety diversity equal opportunity assessment health safety safety ethics transparency impacts product service categories diversity governance bodies gilead workforce demographics employees provided ethnicity data gilead sciences marketing labeling united states privacy regulations restrict collection information many countries also track incidents noncompliance concerning gilead receive government body manage diversity age group manage diversity product service information warnings fines penalties related beyond gender information available labeling marketing labeling practices ratio basic salary remuneration compensation financial benefits gilead incidents noncompliance concerning gilead receive government body women men gileads salary ratio women men globally marketing communications warnings fines penalties related time position marketing labeling practices report pay parity employee category significant locations operations customer privacy substantiated complaints concerning gilead substantiated complaints breaches customer privacy losses concerning losses customer data customer data sustainability ttooppiicc codceode escriptiodnescription res ponse response access medicines hcbpa description actions initiatives promote access medicines around world access health care products priority diseases see year review description priority countries defined access accounting access medicines medicine index hcbpa list products list prequalified gilead three products list prequalified medicinal medicinal products part prequalification products including remdesivir amphotericin b sofosbuvir medicines programme pqp velpatasvir standards board drug safety hcbpa list products listed fda medwatch safety gilead collects adverse events sources globally assesses alerts human medical products database data ongoing basis individual case level well aggregate reports data agencies worldwide sasb index accordance applicable safety regulations furthermore gilead robust comprehensive processes place detection hcbpa number fatalities associated products potential new safety signals products development reported fda adverse event reporting market well disclosure applicable agencies system physicians patients hcbpa number recalls issued total units recalled hcbpa total amount product accepted takeback mission sasb help businesses around reuse disposal world identify manage report sustainability topics hcbpa number fda enforcement actions taken response violations current good matter investors sasb standards differ manufacturing practices cgmp type industry enabling investors companies compare performance company company within industry counterfeit drugs hcbpa description methods technologies used nature gileads medicines makes ensuring authenticity maintain traceability products throughout safety fundamentally important address complex threat supply chain prevent counterfeiting patient safety associated counterfeit diverted drugs gilead maintains inclusive crossfunctional anticounterfeiting team act consisting brand protection legal quality regulatory trades global serialization traceability security supply chain packaging professionals individually functions ensure gilead meets global legal regulatory requirements relating counterfeit drugs supply chain security serialization traceability products regulatory reporting counterfeits product recalls act ensures company informed coordinated approach protect patients counterfeit drugs hcbpa discussion process alerting customers act successfully operated within four key pillars detect business partners potential known risks stop deter report counterfeit drugs educationcollaboration associated counterfeit products prevention detection investigationenforcement safety clinical trial participants hcbpa total amount monetary losses result gilead incur monetary losses result legal legal proceedings associated clinical trials proceedings associated clinical trials developing countries developing countries ttooppiicc codceode escriptiodnescription res ponse response ttooppiicc codceode escriptiodnescription res ponse response access medicines hcbpa description actions initiatives promote access medicines around world counterfeit drugs hcbpa number actions led raids seizure arrests year covid pandemic gilead investigating access health care products priority diseases see year review description andor filing criminal charges related counterfeit ultimately gaining regulatory approval medicine treat priority countries defined access products covid veklury remdesivir act strengthened expanded medicine index access medicines team address anticipated increase counterfeit cases acts key operational pillars prepared company deploy comprehensive patient protection program veklury response substantial hcbpa list products list prequalified gilead three products list prequalified medicinal worldwide demand unforeseen beginning year medicinal products part prequalification products including remdesivir amphotericin b sofosbuvir medicines programme pqp velpatasvir key highlights launched campaign educate law enforcement agencies ministries health worldwide gileadbranded remdesivir product characteristics mode administration legitimate supply chain drug safety hcbpa list products listed fda medwatch safety gilead collects adverse events sources globally assesses alerts human medical products database data ongoing basis individual case level deployed covert overt anticounterfeiting features packaging well aggregate reports data agencies worldwide gileadbranded remdesivir products help deter detect accordance applicable safety regulations furthermore gilead counterfeits robust comprehensive processes place detection hcbpa number fatalities associated products potential new safety signals products development expanded engaged intelligence program include veklury reported fda adverse event reporting market well disclosure applicable agencies remdesivir enhanced detection program provides realtime system physicians patients information illicit offers counterfeit gilead medicines online sellers identifies high priority targets offline investigation hcbpa number recalls issued total units recalled lead criminal referrals andor civil enforcement action expanded online monitoring takedown program illicit offers hcbpa total amount product accepted takeback gilead medicine include vekluryremdesivir reuse disposal collaborated law enforcement industry members share intelligence best practices stop counterfeits hcbpa number fda enforcement actions taken reaching patients response violations current good initiated new investigations referred cases law manufacturing practices cgmp type enforcement successfully took websites online marketplaces listings social media listingsaccounts advertising illicit counterfeit drugs hcbpa description methods technologies used nature gileads medicines makes ensuring authenticity offers gilead medicine online maintain traceability products throughout safety fundamentally important address complex threat supply chain prevent counterfeiting patient safety associated counterfeit diverted drugs gilead maintains inclusive crossfunctional anticounterfeiting team act consisting brand protection legal quality regulatory trades global serialization traceability security supply chain packaging professionals individually functions ensure gilead meets ethical marketing hcbpa total amount monetary losses result legal gilead incur monetary losses result legal global legal regulatory requirements relating counterfeit drugs proceedings associated false marketing claims proceedings associated false marketing claims supply chain security serialization traceability products regulatory reporting counterfeits product recalls act ensures company informed coordinated approach protect patients counterfeit drugs hcbpa description code ethics governing promotion label use products hcbpa discussion process alerting customers act successfully operated within four key pillars detect business partners potential known risks stop deter report counterfeit drugs educationcollaboration associated counterfeit products prevention detection investigationenforcement ttooppiicc codceode escriptiodnescription res ponse response gilead increased rd organization new rd employee recruitment hcbpa discussion talent recruitment retention employees research centers located san francisco bay development retention efforts scientists research development area seattle development teams located throughout personnel world rd organization invested heavily inclusion diversity creating diversity councils chaired senior leaders guide efforts gilead invested technology gain greater access underrepresented talent gilead introduced advancing black leadership strategy blueprint change program allocate budget aimed specifically increasing black hispanic hiring development retention gilead expanded internship program committing rd summer internships aimed ultimately hiring fulltime early talent scientific roles upon graduation additionally gilead invested partnerships several hbcus hispanic serving institutions expanding access diverse talent hcbpa voluntary involuntary turnover rate gilead workforce demographics executivessenior managers b midlevel managers c gilead discloses voluntary turnover number professionals others year review business ethics hcbpa description code ethics governing interactions work healthcare professionals patient organizations payor bodies healthcare professionals others healthcare community right reasons transparent ethical way respect industry standards promotion prescription medicines expectations read understand follow applicable industry standards gilead business conduct manuals bcms required perform role key highlights bcms include ensure always clear legitimate appropriate business purpose interactions promote products appropriately respecting independence work healthcare community ensure information materials accurate fair balanced misleading shared appropriately provide anything value inappropriately influence decision use recommend products photography photos included report taken prior pandemic others taken pandemic individuals photographed adhered relevant local guidelines images appearing either property gilead used permission respective owners legal matters dara burdette rights various trademarks copyrights trade names used business including following gilead gilead sciences ambisome atripla biktarvy cayston complera descovy descovy prep emtriva epclusa eviplera genvoya harvoni hepcludex hepsera jyseleca letairis odefsey ranexa sovaldi stribild tecartus trodelvy truvada truvada prep tybost veklury vemlidy viread vosevi yescarta zydelig gilead sciences inc rights reserved discovery virology report also refers trademarks service marks trade names companies